Pharmaceutical Industry Today

Nitric Oxide Therapy System Market will reach 39 million US$ by the end of 2025

The global Nitric Oxide Therapy System market is valued at 25 million US$ in 2017 and will reach 39 million US$ by the end of 2025, growing at a CAGR of 5.4% during 2018-2025.
Published 04 July 2018
This report studies the global Nitric Oxide Therapy System market status and forecast, categorizes the global Nitric Oxide Therapy System market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung

Durability and lightweight are the meritorious features that increase the demand for portable nitric oxide therapy systems. Relatively low cost, versatility and easy fabrication of the auxiliary holding devices with the main ventilation unit makes fixed nitric oxide therapy systems a lucrative option in the ambulatory care and hospitals.

Request Sample Copy of the Report @ https://www.qyresearch.com/sample-form/form/376042/global-nitric-oxide-therapy-system-market

Hospitals and clinics widely utilize the nitric oxide inhalation therapy in the neonate and intensive care unit to address ailments related to pulmonary disorders and increasing demand for pediatric cardiopulmonary bypass surgery procedures for treating cardiopulmonary ailments. Homecare settings finds huge application of nitric oxide therapy systems for the rehabilitation of geriatric patients suffering with acute respiratory distress syndrome.

North America is the market leader in nitric oxide therapy systems due to the rising prevalence of acute respiratory distress syndrome in the adult population and the presence of key players actively engaged in the manufacturing of nitric oxide therapy systems. Asia Pacific will dominate the market in the near future on account of the rising prevalence of neonate pulmonary hypertension. Competitive market formed due to the emergence of local providers of nitric oxide therapy systems contribute to the growth of Asia Pacific market.

The global Nitric Oxide Therapy System market is valued at 25 million US$ in 2017 and will reach 39 million US$ by the end of 2025, growing at a CAGR of 5.4% during 2018-2025.

Ask for Discount on Research Report@ https://www.qyresearch.com/request-discount/form/376042/global-nitric-oxide-therapy-system-market

The major manufacturers covered in this report

    Bellerophon Therapeutics

    BOC Healthcare

    Dan Hammer Health LTD

    EKU Elektronik GmbH

    GeNO LLC

    International Biomedical

    SLE

    Mallinckrodt Pharmaceuticals

    Praxair, Inc.

    Vapotherm

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

    North America

    Europe

    China

    Japan

    Southeast Asia

    India

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

    Protable System

    Fixed System

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

    Hospitals

    Homecare Settings

    Others

About Us:
 
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

Other Industry News

Ready to start publishing

Sign Up today!